JAK/TYK2

Advertisement

cGxPJobs Banner

Priovant Wins FDA Approval for Lisraya in Dermatomyositis

SILVER SPRING, MARYLAND, Aug 27, 2026 Priovant Therapeutics Inc. has received U.S. Food and Drug Administration (FDA) approval for...

By cGxPwire Editor
August 29, 2026

Read More

Advertisement

cGxPJobs

Directory